Kyriazi Theo Melas, Director at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX), bought 15,000 shares at $19.50 ($293K) on 2009-05-14, disclosed to the SEC on 2009-05-14.
Seasonal purchase ($293k) by Director — this insider has traded VRX in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.50 | 10,000 | $195K | 66.6% |
| 2 | $19.54 | 5,000 | $98K | 33.4% |
| Total | $19.51 avg | 15,000 | $293K | 100% |
| Filing → |